'Pay for Delay'

The EU's competition commissioner issued the final report from investigating the delays in generic drugs coming to the market, reports the Wall Street Journal's Health Blog. The report acknowledged that innovation difficulties and regulation affect the time it takes to get a generic to market and suggested that the EU have a single patent and litigation system.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.